Publication

Sexual behaviors and human papillomavirus vaccine non-initiation among young adult cancer survivors

Downloadable Content

Persistent URL
Last modified
  • 09/19/2025
Type of Material
Authors
    Brooke Cherven, Emory UniversityJames Klosky, Emory UniversityYanjun Chen, University of Alabama BirminghamJocelyn M York, University of Alabama BirminghamKaren Heaton, University of Alabama BirminghamGwendolyn Childs, University of Alabama BirminghamJessica S Flynn, St Jude Childrens Research HospitalJames A Connelly, Vanderbilt UniversityKaren Wasilewski-Masker, Emory UniversityLeslie L Robison, St Jude Childrens Research HospitalMelissa M Hudson, St Jude Childrens Research HospitalLennie F Wong, City of Hope, DuarteSmita Bhatia, University of Alabama BirminghamWendy Landier, University of Alabama Birmingham
Language
  • English
Date
  • 2021-02-06
Publisher
  • SPRINGER
Publication Version
Copyright Statement
  • © 2021, The Author(s), under exclusive licence to Springer Science Business Media, LLC part of Springer Nature
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 15
Issue
  • 6
Start Page
  • 942
End Page
  • 950
Supplemental Material (URL)
Abstract
  • Background: Young adult cancer survivors are at risk for subsequent human papillomavirus (HPV)-related malignancies. High-risk sexual behavior increases risk for HPV acquisition; HPV vaccination protects against infection. We aimed to determine the prevalence of sexual behaviors, factors related to high-risk sexual behaviors, and the relationship between sexual behaviors and HPV vaccine non-initiation among survivors. Methods: Survivors at comprehensive cancer centers, aged 18–26 years and 1–5 years post-treatment, reported sexual behaviors and HPV vaccine initiation (i.e., ≥ 1 dose). Multivariable logistic regression was performed to calculate odds ratios (OR) and 95% confidence intervals (95%CI) for factors associated with high-risk sexual behaviors (age at first intercourse < 16 years, ≥ 3 lifetime sexual partners, or condom use ≤ 50% of the time) and to explore the relationship between sexual behaviors and vaccine non-initiation. Results: Of the 312 participants (48.1% female, median age at cancer diagnosis 17.2 years and at survey 20.9 years), sexual intercourse was reported by 63.1%. Of those reporting intercourse, 74.6% reported high-risk sexual behavior. Factors related to high-risk sexual behavior included currently dating/partnered (OR = 4.39, 95%CI 2.5–7.7, P < 0.001) and perceived susceptibility to HPV (OR = 1.76, 95%CI 1.3-2.5, P < 0.001). Most survivors (75.3%) reported HPV vaccine non-initiation; sexual behaviors were not associated with vaccine non-initiation (P = 0.4). Conclusions: Many survivors participate in high-risk sexual behaviors, yet HPV vaccine initiation rates are low. Factors related to high-risk sexual behaviors can inform interventions to reduce risk for HPV acquisition among survivors. Implications for Cancer Survivors: Cancer survivors participate in sexual behaviors that increase risk for HPV acquisition and would benefit from vaccination.
Author Notes
  • Wendy Landier, PhD, CRNP, FAAN, Institute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama at Birmingham, 1600 7th Ave. S., Lowder 500, Birmingham, AL; Phone: 205-638-2120. Email: wlandier@peds.uab.edu
Keywords

Tools

Relations

In Collection:

Items